Journal of Current Glaucoma Practice

Register      Login

VOLUME 11 , ISSUE 2 ( May-August, 2017 ) > List of Articles

ORIGINAL REASEARCH

Outcomes of Ex-PRESS and Trabeculectomy in a Glaucoma Population of African Origin: One Year Results

Youssef Dib Bustros, Robert Fechtner, Albert S Khouri

Citation Information : Bustros YD, Fechtner R, Khouri AS. Outcomes of Ex-PRESS and Trabeculectomy in a Glaucoma Population of African Origin: One Year Results. J Curr Glaucoma Pract 2017; 11 (2):42-47.

DOI: 10.5005/jp-journals-10028-1221

License: CC BY 3.0

Published Online: 01-08-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim

To compare the efficacy and safety of Ex-PRESS glaucoma filtration surgery to trabeculectomy in African origin patients.

Materials and methods

A retrospective chart review was performed on 56 African American patients undergoing Ex-PRESS glaucoma shunt (E) or trabeculectomy (T) between 2004 and 2012. Data collected included intraocular pressure (IOP) and glaucoma medication use at baseline and postoperative week 1, Month (M) 1, M3, M6, M12. Postoperative interventions including laser suture lysis (LSL) and 5FU injections were analyzed. Complete and qualified success rate, and eyes failing and requiring more surgery were determined. Means, SD, chi-square, and Student's t-test were performed.

Results

A total of 56 subjects (E 28, T 28) were included in the analysis. There was a statistically significant reduction (p < 0.05) in IOP and number of glaucoma medications at all time points compared to baseline for both groups. Extent of IOP reduction between groups was not statistically significant at any time point, except postoperative week 1. Mean number of glaucoma medications between groups was not significant, except at 3 months (lower in EXP group). The cumulative number of postoperative interventions within 3 months (LSL and 5-FU) was significantly greater for the TRAB than EXP (3.89 ± 2.4 vs 2.36 ± 2.2, p = 0.007). Success rates were comparable between both groups (Table 2).

Conclusion

Our study is unique in patients of African origin showing statistical significance in the requirement of less postoperative 5-FU injections during the first 3 months following surgery in the Ex-PRESS group vs the trabeculectomy group. The Ex-PRESS shunt was as effective as trabeculectomy in reducing IOP and use of glaucoma medications up to 1 year.

Clinical significance

The possible benefit of this article is to help guiding ophthalmologists to select the type of glaucoma filtration surgery to undergo in an African American patient with glaucoma.

How to cite this article

Bustros YD, Fechtner R, Khouri AS. Outcomes of Ex-PRESS and Trabeculectomy in a Glaucoma Population of African Origin: One Year Results. J Curr Glaucoma Pract 2017;11(2):42-47.


  1. Surgical management of glaucoma: a review. Clin Exp Ophthalmol 2012 May-Jun;40(4):388–399.
  2. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014 Nov;121(11):2081-2090.
  3. Undertreatment of glaucoma among black americans. N Engl J Med 1991 Nov 14;325(20):1418-1422.
  4. Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important? Br J Ophthalmol 1994 Jun;78(6):466-475.
  5. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev 2012 Sep 12(9):CD004399.
  6. Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma 2001 Jun;10(3):237-249.
  7. Outcomes and bleb-related complications of trabeculectomy. Ophthalmology 2012 Apr; 119(4):712-722.
  8. The Ex-PRESS glaucoma shunt versus trabeculectomy in open-angle glaucoma: a prospective randomized study. Adv Ther 2009 Mar;26(3):336-345.
  9. Surgical undertreatment of glaucoma in black beneficiaries of medicare. Arch Ophthalmol 2000 Apr;118(2):253-256.
  10. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am J Ophthalmol 2001 Sep;132(3):311-320.
  11. Surgical outcomes of the Ex-PRESS glaucoma filtration device in African American and white glaucoma patients. Clinical ophthalmol 2012 Jun;6:955-962.
  12. Risk factors for early filtration failure requiring suture release after primary glaucoma triple procedure with adjunctive mitomycin. Arch Ophthalmol 1999 Sep;117(9):1149-1154.
  13. Long-term outcomes and risk factors for failure with the EX-press glaucoma drainage device. Eye (Lond) 2014 Jan;28(1):1-8.
  14. Wound healing in glaucoma filtering surgery. Surv Ophthalmol 1987 Nov-Dec;32(3):149-170.
  15. A comparison of the Ex-PRESSTM mini glaucoma shunt with standard trabeculectomy in the surgical treatment of glaucoma. Ophthalmic Surg Lasers Imaging 2011 Nov-Dec;42(6):453-459.
  16. Trabeculectomy with ExPRESS: weighing the benefits and cost. Curr Opin Ophthalmol 2013 Mar;24:111-118.
  17. Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient: a prospective randomized study. Eye(Lond) 2012 May;26(5):703-710.
  18. EX-PRESS glaucoma filtration device: Review of clinical experience and comparison with trabeculectomy. Surv Ophthalmol 2015 Jul-Aug; 60(4):327-345.
  19. Randomized, Prospective, Comparative Trial of EX-PRESS Glaucoma Filtration Device versus Trabeculectomy (XVT Study). Am J Ophthalmol 2014 Feb;157(2):443-440.
  20. Does over-expression of transforming growth factor-beta account for the increased morbidity in African-Americans?: Possible clinical study and therapeutic implications. Med Hypotheses 2010 Nov;75(5):418-421.
  21. , Ishida K, Netland PA. Comparison of trabeculectomy with Ex-PRESS miniature glaucoma device implanted under scleral flap. J Glaucoma 2007 Jan;16(1):14-19.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.